Kura Oncology (KURA) Return on Capital Employed (2011 - 2026)
Kura Oncology (KURA) reported Return on Capital Employed of 3.45% for Q1 2026, up 2463.0% year-over-year from 0.13% in Q1 2025, and down 212.45% on a QoQ basis from 1.1% in Q4 2025.
Kura Oncology (KURA) has 7 years of Return on Capital Employed data on file, last reported at 3.45% in Q1 2026.
- Quarterly Return on Capital Employed rose 2463.0% year-over-year to 3.45% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.45% (up 2463.0% YoY) and the FY2025 annual result came in at 48.02%, down 1128.0% from the prior year.
- Return on Capital Employed slipped to 3.45% in Q1 2026 per KURA's latest filing, from 1.1% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 1.1% in Q4 2025 and bottomed at 40.57% in Q3 2025.
- The 3-year median for Return on Capital Employed is 28.08% (2025), against an average of 22.43%.
- Peak annual rise in Return on Capital Employed reached 3040 bps in 2025, while the deepest fall reached 1760 bps in 2025.
- Tracing KURA's Return on Capital Employed over 3 years: stood at 31.5% in 2024, then surged by 96 bps to 1.1% in 2025, then sank by 212 bps to 3.45% in 2026.
- Per Business Quant, the three latest KURA Return on Capital Employed figures stand at 3.45% (Q1 2026), 1.1% (Q4 2025), and 40.57% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 21.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.19% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.34% |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | -3.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.45% |
| Dec 31, 2025 | -1.10% |
| Sep 30, 2025 | -40.57% |
| Jun 30, 2025 | -33.21% |
| Mar 31, 2025 | -28.08% |
| Dec 31, 2024 | -31.50% |
| Sep 30, 2024 | -33.63% |
| Jun 30, 2024 | -19.87% |
| Mar 31, 2024 | -10.48% |
| Dec 31, 2014 | 1.03% |
| Mar 31, 2013 | 23.00% |
| Dec 31, 2012 | 23.83% |
| Sep 30, 2012 | 26.26% |
| Jun 30, 2012 | 29.96% |
| Mar 31, 2012 | 28.47% |
| Dec 31, 2011 | 35.45% |
| Sep 30, 2011 | 40.02% |
| Jun 30, 2011 | 37.64% |